SCHEDULE OF PRO FORMA FINANCIAL INFORMATION (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Preferred Stock authorized	2,000,000		2,000,000
Preferred Stock issued	0		0
Common Stock authorized	60,000,000		60,000,000
Common Stock issued	1,887,535		1,877,970
Net Loss	$ (4,070,457)	$ (2,538,500)
Basic net loss per share	$ (2.16)	$ (1.38)
Diluted net loss per share	$ (2.16)	$ (1.38)
Weighted average common and common equivalent shares, basic	1,880,185	1,840,129
Weighted average common and common equivalent shares, diluted	1,880,185	1,840,129
Reverse Stock Split [Member]
Preferred Stock authorized			2,000,000
Preferred Stock authorized, pro forma			2,000,000
Preferred Stock issued			0
Preferred Stock issued, pro forma			0
Common Stock authorized			60,000,000
Common Stock authorized, pro forma			60,000,000
Common Stock issued			46,949,240
Common Stock issued, pro forma			1,887,969
Net Loss			$ (15,549,244)
Net Loss, pro forma			$ (15,549,244)
Basic net loss per share			$ (0.34)
Diluted net loss per share			(0.34)
Basic net loss per share, pro forma			(8.38)
Diluted net loss per share, pro forma			$ (8.38)
Weighted average common and common equivalent shares, basic			46,399,137
Weighted average common and common equivalent shares, diluted			46,399,137
Weighted average common and common equivalent shares, basic pro forma			1,855,965
Weighted average common and common equivalent shares, diluted pro forma			1,855,965